PAAG'S MISSION The Patient Advisory & Advocacy Group (“PAAG”) is committed to represent and pursue the best interests of the opiate dependent patient and all other substance dependent patients or clients in the population served by Aegis Medical Systems, Inc. (“AMS”), Aegis Institute, Inc., (“AI”) and Nationwide Medical Group, Inc. (“NMG”), collectively hereafter called “Aegis”. PAAG will support Aegis efforts to improve and enhance patient care through research and development of new treatment modalities, provision of extensive and comprehensive treatment services as well as raising the effectiveness of the existing programs.

PAAG will provide fair and honest advice to Aegis and government agencies regarding patients’ unmet needs, recommended changes to Aegis policies, protocols and procedures (“PP&Ps”), as well as any unlawful or unfair practices taking place in Aegis.

PAAG is also committed to express concerns and opinions on provisions of the law and regulations, which are adversarial to the best interest of the patients, and will do so whether independently or jointly together with Aegis.

Members of PAAG act professionally, conservatively and constructively and shall in no way compromise their integrity by taking advantage of their influential position.